Firocoxib 是一种高选择性的COX-2抑制剂。
别名:ML 1785713
Firocoxib is a coxib exhibiting high selectivity to inhibit COX-2. In vitro canine whole blood assays have demonstrated Firocoxib to be 350–430-fold more selective for COX-2 than for COX-1. COX-1 is constitutively expressed and enzymatically active in a variety of sites, including the stomach, intestine, kidneys, and platelets. COX-1 is the isoform largely responsible for the physiologic functions of eicosanoids, including gastric mucosal protection, renal blood flow, and vascular hemostasis. COX-2 expression is primarily induced by mediators such as serum growth factors, cytokines, and mitogens. COX-2 is primarily responsible for the synthesis of eicosanoids associated with inflammation.
体外实验* | |
---|---|
细胞系 | isolated peripheral blood mononuclear cells |
方法 | Peripheral blood mononuclear cells were isolated by density gradient centrifugation and incubated at 37°C with medium alone, firocoxib (100 ng/mL), LPS (1 ng/mL or 1 μg/mL), or combinations of firocoxib and both LPS concentrations. After 4 hours, supernatants were collected and tested for prostaglandin E2 (PGE2) concentration with an enzyme inhibition assay, and gene expression in cell lysates was measured with PCR assays. |
浓度 | 100 ng/mL |
处理时间 | 4h |
*上述方法来自公开文献,仅供相同目的实验参考。如实验目的、材料、方法不同,请参考其他文献。
体内实验* | |
---|---|
动物模型 | Mouse Model of Incisional Pain by objective measurement of mechanical allodynia and thermal hyperalgesia using von Frey and Hargreaves equipment |
配制 | diluted in sterile 0.9% physiologic saline |
剂量 | 10 or 20 mg/kg |
给药处理 | intraperitoneally |
*上述方法来自公开文献,仅供相同目的实验参考。如实验目的、材料、方法不同,请参考其他文献。
分子量 | 336.4 |
分子式 | C17H20O5S |
CAS号 | 189954-96-9 |
溶解性(25°C) | DMSO ≥ 45 mg/mL |
储存条件 | -20°C, protect from light, sealed |
运输方式 | 冰袋运输,根据产品的不同,可能会有相应调整。 |
*下述溶液配置方法仅为基于分子量计算出的理论值。不同产品在配置溶液前,需考虑其在不同溶剂中的溶解度限制。
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.9727 mL | 14.8633 mL | 29.7265 mL |
5 mM | 0.5945 mL | 2.9727 mL | 5.9453 mL |
10 mM | 0.2973 mL | 1.4863 mL | 2.9727 mL |
小鼠 | 大鼠 | 兔 | 豚鼠 | 仓鼠 | 狗 | |
重量 (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
体表面积 (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km 系数 | 3 | 6 | 12 | 8 | 5 | 20 |
动物 A (mg/kg) = 动物 B (mg/kg) × | 动物 B的Km系数 |
动物 A的Km系数 |
例如,依据体表面积折算法,将化合物用于小鼠的剂量20 mg/kg 换算成大鼠的剂量,需要将20 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到化合物用于大鼠的等效剂量为10 mg/kg。
[1] Sarah A Wagner, et al. Pharmacokinetics of oral firocoxib in un-weaned calves
[2] Josh R Donnell, et al. Use of firocoxib for the treatment of equine osteoarthritis
[3] Bachir Latli, et al. Synthesis of stable isotope-labelled firocoxib
其他相关的COX产品 |
---|
Birch triterpenes
Birch triterpenes是一种环氧化酶-2(COX-2)抑制剂,可用于大疱性表皮松解症的相关研究。 |
Naproxcinod
Naproxcinod是一种首创的(first-in-class)环氧合酶抑制性一氧化氮供体 (CINODs),具有镇痛和抗炎活性,可用于骨关节炎和炎症的相关研究。 |
Hamaudol
Hamaudol 是从 Saposhnikovia divaricata 中分离出的一种色酮。 |
(±)-Catechin
(±)-Catechin (rel-Cianidanol) 是 Catechin 的外消旋体。 |
PYZ18
PYZ18 是一种选择性的 COX-2 抑制剂,其 IC50 值为 7.07 μM。 |
产品仅供科学研究或药证申报的用途使用,不为任何个人或者非科研性质的其他用途提供服务。
Copyright © 2010-2022 AbMole版权所有 沪ICP备16047849号 沪公网安备 31011502012228号